DASHENLIN PHARMACEUTICAL GROUP revenue breakdown overview

DASHENLIN PHARMACEUTICAL GROUP revenue for the last year amounted to 24.53 B CNY, the most of which — 20.51 B CNY — came from its highest performing source at the moment, Retail, the year earlier bringing 19.24 B CNY. The greatest contribution to the revenue figure was made by China — last year it brought DASHENLIN PHARMACEUTICAL GROUP 24.53 B CNY, and the year before that — 21.25 B CNY.